In Vitro Assessment of the Extended 21-Day Microbial Barrier Provided by the Exofin Fusion Surgical Incision Closure System
Surgical Infections · 2025
DOI: 10.1089/sur.2024.207 ↗Kurz gefasst
Fachartikel in der Zeitschrift Surgical Infections, 2025. Verfasst von Chaitanya Dev Pannu. Beteiligte Einrichtung: Royal National Orthopaedic Hospital, London, United Kingdom. Hauptthemen laut MEDLINE: Tissue Adhesives, Bacteria, Cyanoacrylates, Wound Closure Techniques. Die Arbeit nennt 24 Literaturangaben.
Abstract (Originalsprache)
Background
Tissue adhesives are increasingly being used as alternatives to traditional sutures and staples in surgical incision closure applications. Exofin Fusion, a novel cyanoacrylate-based adhesive with a mesh, has been developed to enhance surgical incision closure. This study investigates the microbial barrier effectiveness of Exofin Fusion.
Methods
An in vitro assessment of 35 plates, including challenge organisms, negative controls, and positive controls, was conducted by an independent research organization, North American Science Associates, Inc (NAMSA), USA. Exofin Fusion was applied to the plates aseptically. Each plate was then inoculated with specific challenge organisms. Observations for visible growth or color changes in the media were made over a 21-day period.
Results
The results demonstrated no growth or color changes on test plates for common pathogens such as Staphylococcus aureus , Staphylococcus epidermidis , Methicillin-resistant Staphylococcus aureus , Pseudomonas aeruginosa , Escherichia coli , and Aspergillus brasiliensis throughout the 21-day period. Candida albicans showed no growth or color changes up to day 20; however, two out of five replicates exhibited growth on day 21.
Conclusions
The study confirms the microbial barrier properties of Exofin Fusion, as it effectively prevents the penetration of challenge organisms for the entire test period. Despite the growth of C. albicans in two replicates on day 21, the adhesive demonstrates remarkable efficacy in protecting against microbial infiltration. These findings suggest the potential clinical utility of Exofin Fusion in surgical incision closure applications, highlighting its significance in healthcare settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Royal National Orthopaedic Hospital, London, United Kingdom.
ORCID-Profile: Chaitanya Dev Pannu
Zitieren
APA
Pannu, C. D. (2025). In Vitro Assessment of the Extended 21-Day Microbial Barrier Provided by the Exofin Fusion Surgical Incision Closure System. Surgical Infections. https://doi.org/10.1089/sur.2024.207
Vancouver
Pannu CD. In Vitro Assessment of the Extended 21-Day Microbial Barrier Provided by the Exofin Fusion Surgical Incision Closure System. Surgical Infections. 2025. doi:10.1089/sur.2024.207
BibTeX
@article{Pannu2025,
author = {Pannu, Chaitanya Dev},
title = {In Vitro Assessment of the Extended 21-Day Microbial Barrier Provided by the Exofin Fusion Surgical Incision Closure System},
journal = {Surgical Infections},
year = {2025},
doi = {10.1089/sur.2024.207}
}
EUVIMED